Literature DB >> 21967146

Histone deacetylase inhibitors from Burkholderia thailandensis.

Paul Klausmeyer1, Suzanne M Shipley, Karina M Zuck, Thomas G McCloud.   

Abstract

Bioactivity-guided fractionation of an extract of Burkholderia thailandensis led to the isolation and identification of a new cytotoxic depsipeptide and its dimer. Both compounds potently inhibited the function of histone deacetylases 1 and 4. The monomer, spiruchostatin C (2), was tested side by side with the clinical depsipeptide FK228 (1, Istodax, romidepsin) in a murine hollow fiber assay consisting of 12 implanted tumor cell lines. Spiruchostatin C (2) showed good activity toward LOX IMVI melanoma cells and NCI-H522 non small cell lung cancer cells. Overall, however, FK228 (1) showed a superior in vivo antitumor profile in comparison to the new compound.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967146      PMCID: PMC3204006          DOI: 10.1021/np200532d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  17 in total

1.  Configuration and racemization determination of cysteine residues in peptides by chiral derivatization and HPLC: application to oxytocin peptides.

Authors:  S Szabó; G Szókán; A M Khlafulla; M Almás; C Kiss; A Rill; I Schön
Journal:  J Pept Sci       Date:  2001-06       Impact factor: 1.905

2.  FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.

Authors:  Ryohei Furumai; Akihisa Matsuyama; Nobuyuki Kobashi; Kun-Hyung Lee; Makoto Nishiyama; Hidenori Nakajima; Akito Tanaka; Yasuhiko Komatsu; Norikazu Nishino; Minoru Yoshida; Sueharu Horinouchi
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 3.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

4.  YM-30059, a novel quinolone antibiotic produced by Arthrobacter sp.

Authors:  K Kamigiri; T Tokunaga; M Shibazaki; B Setiawan; R M Rantiatmodjo; M Morioka; K Suzuki
Journal:  J Antibiot (Tokyo)       Date:  1996-08       Impact factor: 2.649

5.  Products of performic acid oxidation and acid hydrolysis of S-carboxymethylcysteine and related compounds.

Authors:  K Takahashi
Journal:  J Biochem       Date:  1973-12       Impact factor: 3.387

6.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination.

Authors:  N Shigematsu; H Ueda; S Takase; H Tanaka; K Yamamoto; T Tada
Journal:  J Antibiot (Tokyo)       Date:  1994-03       Impact factor: 2.649

Review 7.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

8.  Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.

Authors:  Cheng Wang; Leonhard M Henkes; Leah B Doughty; Min He; Difei Wang; Franz-Josef Meyer-Almes; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2011-07-27       Impact factor: 4.050

9.  In vivo cultivation of tumor cells in hollow fibers.

Authors:  M G Hollingshead; M C Alley; R F Camalier; B J Abbott; J G Mayo; L Malspeis; M R Grever
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

View more
  11 in total

1.  Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264.

Authors:  Cheng Wang; Creston J Flemming; Yi-Qiang Cheng
Journal:  Medchemcomm       Date:  2012-08-01       Impact factor: 3.597

Review 2.  An overview of naturally occurring histone deacetylase inhibitors.

Authors:  Bumki Kim; Jiyong Hong
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Revised genome sequence of Burkholderia thailandensis MSMB43 with improved annotation.

Authors:  Ying Zhuo; Lin Liu; Qi Wang; Xiangyang Liu; Biao Ren; Mei Liu; Peixiang Ni; Yi-Qiang Cheng; Lixin Zhang
Journal:  J Bacteriol       Date:  2012-09       Impact factor: 3.490

4.  Burkholderia as a Source of Natural Products.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  J Nat Prod       Date:  2019-07-11       Impact factor: 4.050

5.  Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

Authors:  Xiangyang Liu; Sreya Biswas; Michael G Berg; Christopher M Antapli; Feng Xie; Qi Wang; Man-Cheng Tang; Gong-Li Tang; Lixin Zhang; Gideon Dreyfuss; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2013-03-21       Impact factor: 4.050

6.  Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil.

Authors:  Kuan Shion Ong; Yoong Kit Aw; Learn Han Lee; Catherine M Yule; Yuen Lin Cheow; Sui Mae Lee
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

7.  Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228.

Authors:  Xiangyang Liu; Feng Xie; Leah B Doughty; Qi Wang; Lixin Zhang; Xueting Liu; Yi-Qiang Cheng
Journal:  Synth Syst Biotechnol       Date:  2018-11-05

8.  Cyclo-(-l-prolyl-l-valinyl-) from Burkholderia thailandensis MSMB43.

Authors:  Xiang-Yang Liu; Cheng Wang; Yi-Qiang Cheng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-10-20

9.  FK228 from Burkholderia thailandensis MSMB43.

Authors:  Xiang-Yang Liu; Cheng Wang; Yi-Qiang Cheng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-23

10.  Chromopeptide A, a highly cytotoxic depsipeptide from the marine sediment-derived bacterium Chromobacterium sp. HS-13-94.

Authors:  Zhenfang Zhou; Xin Wang; Hui Zhang; Jingya Sun; Linghui Zheng; Hongchun Liu; Jidong Wang; Aijun Shen; Meiyu Geng; Yuewei Guo
Journal:  Acta Pharm Sin B       Date:  2015-01-07       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.